
Pluri Inc.
PLUR | TA
Overview
Corporate Details
- ISIN(s):
- US72942G2030
- LEI:
- Country:
- Israel
- Address:
- Park Building No. 5, 3508409 Haifa
- Website:
- https://pluri-biotech.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pluri Inc., formerly Pluristem Therapeutics, is a biotechnology company that researches, develops, and manufactures cell-based products and therapeutics. The company specializes in its proprietary 3D cell-expansion technology platform, which is used to create solutions for commercial use aimed at improving human well-being and sustainability. Pluri develops products from placenta-based cells for applications across the medical and pharmaceutical industries, often in collaboration with research partners and academic institutions.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Pluri Inc..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-07-03 22:43 |
Post-Annual General Meeting Information
Immediate Report
|
Hebrew (modern) | 224.6 KB | |
2025-07-03 22:43 |
Foreign Filer Report
Immediate Report
|
English | 36.5 KB | |
2025-07-02 01:15 |
Director's Dealing
Other Report or Announcement
|
English | 267.8 KB | |
2025-07-02 01:15 |
Foreign Filer Report
Other Report or Announcement
|
English | 36.4 KB | |
2025-05-28 21:57 |
Proxy Solicitation & Information Statement
mediate Report of Meeting to be held on June 30, 2025
|
English | 1.4 MB | |
2025-05-28 21:57 |
Pre-Annual General Meeting Information
mediate Report of Meeting to be held on June 30, 2025
|
English | 184.6 KB | |
2025-05-28 01:52 |
Annual Report
Materials for Annual Meeting - Annual Report for 30.06.2024
|
English | 346.4 KB | |
2025-05-28 01:52 |
Foreign Filer Report
Materials for Annual Meeting - Annual Report for 30.06.2024
|
English | 36.3 KB | |
2025-05-28 01:36 |
Proxy Solicitation & Information Statement
Immediate Report of Meeting to be held on June 30, 2025, proxy
|
English | 1.4 MB | |
2025-05-28 01:36 |
Pre-Annual General Meeting Information
Immediate Report of Meeting to be held on June 30, 2025, proxy
|
English | 161.1 KB | |
2025-05-27 17:56 |
Pre-Annual General Meeting Information
FORM 8K – Updated Regurding Annual Meeting Date
|
English | 112.3 KB | |
2025-05-27 17:56 |
Foreign Filer Report
FORM 8K – Updated Regurding Annual Meeting Date
|
English | 36.3 KB | |
2025-05-20 17:26 |
Major Shareholding Notification
Form 13D/A-Yaky Yanay
|
English | 168.9 KB | |
2025-05-20 17:26 |
Foreign Filer Report
Form 13D/A-Yaky Yanay
|
English | 36.2 KB | |
2025-05-15 16:02 |
Management Discussion and Analysis
Pluri CEO Issues Shareholder Letter
|
English | 110.5 KB |
Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Pluri Inc. via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |